HONG KONG, March 31, 2021 - Great Bay Bio Holdings Limited (hereinafter referred to as “GBB”) is pleased to announce that the company’s self-developed AI-enabled cell culture media development platform, AlfaMedX®, is officially launched. AlfaMedX® is created through the convergence between AI, big data and biotechnology, enabling the development of optimized cell culture media within a short timef